Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.52 CHF | -2.00% | -2.32% | +14.17% |
Apr. 23 | DOCMORRIS : Deutsche Bank remains its Buy rating | ZD |
Apr. 19 | DOCMORRIS : Hauck & Aufhauser gives a Buy rating | ZD |
Sales 2024 * | 1.18B 1.3B | Sales 2025 * | 1.61B 1.76B | Capitalization | 1.01B 1.11B |
---|---|---|---|---|---|
Net income 2024 * | -84M -91.98M | Net income 2025 * | -20M -21.9M | EV / Sales 2024 * | 1.07 x |
Net Debt 2024 * | 247M 270M | Net Debt 2025 * | 280M 307M | EV / Sales 2025 * | 0.81 x |
P/E ratio 2024 * |
-12.7
x | P/E ratio 2025 * |
-55.6
x | Employees | 1,453 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.58% |
Latest transcript on DocMorris AG
1 day | +2.80% | ||
1 week | -7.31% | ||
Current month | -4.75% | ||
1 month | +1.59% | ||
3 months | +10.72% | ||
6 months | +124.61% | ||
Current year | +16.95% |
Managers | Title | Age | Since |
---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 59 | 14-12-31 |
Founder | 66 | 93-04-05 | |
Marcel Ziwica
DFI | Director of Finance/CFO | 49 | 00-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 10-03-31 | |
Florian Seubert
BRD | Director/Board Member | 51 | 19-05-22 |
Founder | 66 | 93-04-05 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.00% | 10 M€ | -3.35% | - | |
0.00% | 34 M€ | +2.35% | - | |
0.00% | 26 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 84.2 | -2.38% | 23 404 |
24-04-24 | 86.25 | +2.80% | 104,125 |
24-04-23 | 83.9 | +1.33% | 52,640 |
24-04-22 | 82.8 | +1.22% | 81,398 |
24-04-19 | 81.8 | -5.10% | 169,351 |
Delayed Quote Swiss Exchange, April 24, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.95% | 1.11B | |
-31.79% | 15.36B | |
-36.70% | 10.16B | |
+9.74% | 6.13B | |
-10.81% | 6.01B | |
-35.38% | 5.65B | |
-0.73% | 4.71B | |
+51.51% | 4.33B | |
-11.96% | 3.58B | |
-6.33% | 3.1B |
- Stock Market
- Equities
- ROSE Stock